AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24026632 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 22309902 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA) at PC-5 and PC-6 points
Number of subjects: 40
Study 22309902 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine (NE) as a vasoconstrictor
Number of subjects: 40
Study 20435858 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (HS) inhalation for 4 weeks, twice daily
Number of subjects: 20
Study 20435858 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (IS) inhalation for 4 weeks, twice daily
Number of subjects: 20
Study 18388031 — intervention group
Group type: EXPERIMENTAL
Intervention: cilostazol (200 mg/d)
Number of subjects: 60
Study 18388031 — intervention group
Group type: EXPERIMENTAL
Intervention: pentoxifylline (1200 mg/d)
Number of subjects: 60
Study 18388031 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study 21693182 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 19
Study 15632795 — intervention group
Group type: EXPERIMENTAL
Intervention: Time Tradeoff (TTO) technique with tailored time frame and simplified presentation format
Number of subjects: 40
Study 15632795 — intervention group
Group type: EXPERIMENTAL
Intervention: Time Tradeoff (TTO) technique (4 combinations of time frame and presentation format)
Number of subjects: 40
Study 12108312 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose regimen of quinine (20 mg salt/kg initial loading dose, followed by 10 mg salt/kg maintenance dose)
Number of subjects: 72
Study 12108312 — intervention group
Group type: COMPARATOR
Intervention: Regimen without loading dose (15 mg salt/kg)
Number of subjects: 72
Study 12108312 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose regimen of quinine
Number of subjects: 72
Study 12108312 — intervention group
Group type: COMPARATOR
Intervention: Regimen without loading dose
Number of subjects: 72
Study 12108312 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 72
Study 9693348 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive treatment
Number of subjects: 17
Study 9693348 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural treatment
Number of subjects: 17
Study 9693348 — intervention group
Group type: COMPARATOR
Intervention: Control period (no intervention)
Number of subjects: 17
Study 7814759 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular implant-retained overdentures
Number of subjects: 0
Study 7814759 — intervention group
Group type: COMPARATOR
Intervention: Conventional complete dentures
Number of subjects: 0
Study 7814759 — intervention group
Group type: EXPERIMENTAL
Intervention: Two permucosal cylindric implants
Number of subjects: 0
Study 7814759 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmandibular implant
Number of subjects: 0
Study 2530644 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture bite size (0.3, 0.6, 0.9, 1.2, 1.5, and 1.8 cm)
Number of subjects: 346
Study 2530644 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascial thickness
Number of subjects: 346
Study 2530644 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture diameter (00, 0, 1, and 2)
Number of subjects: 346
Study 2530644 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture bite size (1.2 to 1.5 cm)
Number of subjects: 346
Study 953529 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarettes with 30% NSM tobacco substitute
Number of subjects: 200
Study 953529 — intervention group
Group type: COMPARATOR
Intervention: Conventional cigarettes
Number of subjects: 200
Study 11573634 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 2.5 mg plus fentanyl 25 microg (group F)
Number of subjects: 62
Study 11573634 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 2.5 mg plus diamorphine 250 microg (group D)
Number of subjects: 62
Study 30864534 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) treatment
Number of subjects: 0
Study 30864534 — intervention group
Group type: COMPARATOR
Intervention: Transfusion threshold groups
Number of subjects: 0
Study 28664420 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive treatment beliefs
Number of subjects: 289
Study 28664420 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative treatment beliefs
Number of subjects: 289
Study 28664420 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom severity (WOMAC)
Number of subjects: 289
Study 28664420 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective norm
Number of subjects: 289
Study 26488144 — intervention group
Group type: EXPERIMENTAL
Intervention: iMHere system with usual care
Number of subjects: 23
Study 26488144 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 23
Study 24641883 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.6 g/kg/d protein (2×‐RDA)
Number of subjects: 33
Study 24641883 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.4 g/kg/d protein (3×‐RDA)
Number of subjects: 33
Study 24641883 — intervention group
Group type: COMPARATOR
Intervention: 0.8 g/kg/d protein (RDA)
Number of subjects: 33
Study 24984529 — intervention group
Group type: EXPERIMENTAL
Intervention: Omron HEM-907XL BP device
Number of subjects: 6460
Study 24984529 — intervention group
Group type: COMPARATOR
Intervention: Mercury sphygmomanometer
Number of subjects: 6460
Study 22254072 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplements
Number of subjects: 218
Study 22254072 — intervention group
Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 218
Study 22254072 — intervention group
Group type: COMPARATOR
Intervention: Dietary calcium intake
Number of subjects: 218
Study 22254072 — intervention group
Group type: EXPERIMENTAL
Intervention: Total calcium intake with supplements
Number of subjects: 218
Study 17353869 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal insemination (IPI)
Number of subjects: 71
Study 17353869 — intervention group
Group type: EXPERIMENTAL
Intervention: Fallopian sperm perfusion (FSP)
Number of subjects: 71
Study 17353869 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI)
Number of subjects: 71
Study 15986266 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive intravenous and oral hydration
Number of subjects: 425
Study 12560310 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (70 mg x kg(‐1) at induction followed by 30 mg x kg(‐1) x hr(‐1))
Number of subjects: 20
Study 12560310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 10329891 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy (betamethasone 12 mg IM, repeated after 24 hours)
Number of subjects: 218
Study 10329891 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy
Number of subjects: 218
Study 10329891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study 8630581 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled albuterol
Number of subjects: 13
Study 2007038 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: Increased fresh gas flow and manually injecting air into the cuff
Number of subjects: 32
Study 2007038 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: Insufflation with oxygen to maintain cuff pressure at 25 to 28 mmHg
Number of subjects: 32
Study 2007038 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C: Injection of 8 ml mixture of 2% lidocaine hydrochloride jelly and saline at a dilution of 1:3
Number of subjects: 32
Study 2007038 — intervention group
Group type: EXPERIMENTAL
Intervention: Group D: Injection of 8 ml mixture of 2% lidocaine hydrochloride jelly and saline at a dilution of 1:1
Number of subjects: 32
Study 6174165 — intervention group
Group type: EXPERIMENTAL
Intervention: vincristin, methotrexate, bleomycin and cis‐platin
Number of subjects: 151
Study 6174165 — intervention group
Group type: COMPARATOR
Intervention: detorubicin
Number of subjects: 151
Study 31911641 — intervention group
Group type: EXPERIMENTAL
Intervention: NI‐NAVA
Number of subjects: 30
Study 31911641 — intervention group
Group type: COMPARATOR
Intervention: NIPPV
Number of subjects: 30
Study 31064808 — intervention group
Group type: EXPERIMENTAL
Intervention: Meningococcal B (4CMenB) vaccine
Number of subjects: 4096
Study 31064808 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated school leavers
Number of subjects: 4096
Study 30371895 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate 1000-mg + prednisone 5-mg + ADT (AAP group)
Number of subjects: 70
Study 30371895 — intervention group
Group type: COMPARATOR
Intervention: ADT + Placebos (Placebo group)
Number of subjects: 70
Study 26245497 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day dexamethasone (8 mg IV on day 1, followed by oral dexamethasone on days 2 and 3)
Number of subjects: 617
Study 26245497 — intervention group
Group type: COMPARATOR
Intervention: Single-dose dexamethasone (8 mg IV on day 1)
Number of subjects: 617
Study 26245497 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 617
Study 25128185 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment methods (mass mailing, email)
Number of subjects: 599
Study 25128185 — intervention group
Group type: EXPERIMENTAL
Intervention: Email recruitment method
Number of subjects: 599
Study 25128185 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening website
Number of subjects: 599
Study 25128185 — intervention group
Group type: EXPERIMENTAL
Intervention: Ineligibility criteria
Number of subjects: 599
Study 22659656 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol (500 mg/d) plus levamlodipine besylate (2.5 mg/d) plus benazepril (10 mg/d)
Number of subjects: 40
Study 22659656 — intervention group
Group type: COMPARATOR
Intervention: Control group (levamlodipine besylate 2.5 mg/d plus benazepril 10 mg/d)
Number of subjects: 40
Study 22659656 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal group (healthy individuals)
Number of subjects: 40
Study 19070356 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid
Number of subjects: 0
Study 19070356 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination inhaled corticosteroid with a long-acting beta-agonist
Number of subjects: 0
Study 19070356 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukotriene receptor antagonist
Number of subjects: 0
Study 17187165 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg nightly for one year
Number of subjects: 112
Study 17187165 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil 50 or 100 mg as needed for 12 months
Number of subjects: 112
Study 17187165 — intervention group
Group type: COMPARATOR
Intervention: Non-medicated men with ED
Number of subjects: 112
Study 15992629 — intervention group
Group type: EXPERIMENTAL
Intervention: Reperfusion therapy
Number of subjects: 533
Study 15992629 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 533
Study 11985634 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial (cortical) magnetic stimulation
Number of subjects: 26
Study 11985634 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral (mastoid) magnetic stimulation
Number of subjects: 26
Study 11985634 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of laryngeal muscle response latencies in patients
Number of subjects: 26
Study 9771058 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology treatment (14 sessions over four months)
Number of subjects: 3
Study 9771058 — intervention group
Group type: COMPARATOR
Intervention: Non-treatment group (control)
Number of subjects: 3
Study 7636393 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (intraperitoneally) during the first 3 days
Number of subjects: 11
Study 7636393 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 peritonitis episodes studied previously)
Number of subjects: 11
Study 7636393 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (discontinued)
Number of subjects: 11
Study 2655436 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose 300 mg
Number of subjects: 12
Study 2655436 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose 100 mg
Number of subjects: 12
Study 2655436 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose 30 g
Number of subjects: 12
Study 369673 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-recording and monthly home visits
Number of subjects: 140
Study 369673 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-recording only
Number of subjects: 140
Study 369673 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly home visits only
Number of subjects: 140
Study 369673 — intervention group
Group type: COMPARATOR
Intervention: Neither self-recording nor monthly home visits
Number of subjects: 140
Study 31631999 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity PR
Number of subjects: 0
Study 31631999 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity PR
Number of subjects: 0
Study 31631999 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity PR
Number of subjects: 0
Study 28399611 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue-water infusion colonoscopy (BWIC)
Number of subjects: 1065
Study 28399611 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 1065
Study 25688602 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week multidimensional home-based exercise program (experimental)
Number of subjects: 209
Study 25688602 — intervention group
Group type: COMPARATOR
Intervention: Baseline physical activity counseling (control)
Number of subjects: 209
Study 23428938 — intervention group
Group type: EXPERIMENTAL
Intervention: Health priming for soft drink brand evaluation
Number of subjects: 191
Study 23428938 — intervention group
Group type: EXPERIMENTAL
Intervention: Health priming for breakfast cereal brand evaluation
Number of subjects: 191
Study 21177516 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VRET)
Number of subjects: 60
Study 21177516 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-Aided Exposure with Therapist's Assistance (CAE-T)
Number of subjects: 60
Study 21177516 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Administered Computer-Aided Exposure (CAE-SA)
Number of subjects: 60
Study 19761717 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin (DHA) 300 mg daily for 2 days
Number of subjects: 18
Study 19761717 — intervention group
Group type: COMPARATOR
Intervention: Artesunate 300 mg daily for 2 days
Number of subjects: 18
Study 17514186 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (titrated to 10 mg daily)
Number of subjects: 44
Study 17514186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 15496603 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow milk formula with 72 mg/L supplemental ribonucleotides (FN)
Number of subjects: 477
Study 15496603 — intervention group
Group type: COMPARATOR
Intervention: Cow milk formula without supplemental ribonucleotides (F)
Number of subjects: 477
Study 15496603 — intervention group
Group type: COMPARATOR
Intervention: Human milk formula (HMF)
Number of subjects: 477
Study 11464223 — intervention group
Group type: EXPERIMENTAL
Intervention: Mayonnaise containing phytosterols (PS) dissolved in diacylglycerol (DG) (500 mg/day PS, 10 g/day DG)
Number of subjects: 12
Study 11464223 — intervention group
Group type: COMPARATOR
Intervention: Mayonnaise containing phytosterols (PS) dispersed in triacylglycerol (TG) (500 mg/day PS, 10 g/day TG)
Number of subjects: 12
Study 10609770 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol
Number of subjects: 11
Study 10609770 — intervention group
Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 11
Study 7602354 — intervention group
Group type: EXPERIMENTAL
Intervention: Edatrexate (EDX) at an initial dose of 80 mg/m2/wk (later reduced to 70 mg/m2/wk)
Number of subjects: 273
Study 7602354 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) at a dose of 40 mg/m2/wk
Number of subjects: 273
Study 2351794 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 39
Study 2351794 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 39
Study 380492 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 2
Study 380492 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamfetamine
Number of subjects: 2
Study 380492 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 2
Study 380492 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine
Number of subjects: 2
Study 30138128 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy (using an ice pack)
Number of subjects: 16
Study 30138128 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (sham)
Number of subjects: 16
Study 28122376 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitive Skin (SS)
Number of subjects: 29
Study 28122376 — intervention group
Group type: COMPARATOR
Intervention: Atopic Dermatitis (AD)
Number of subjects: 29
Study 28122376 — intervention group
Group type: COMPARATOR
Intervention: Non-Sensitive Skin (NSS)
Number of subjects: 29
Study 28122376 — intervention group
Group type: COMPARATOR
Intervention: Allergic Rhinoconjunctivitis (AR)
Number of subjects: 29
Study 24504872 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive cardiac rehabilitation (12 weeks of exercise training and one year of psycho-educational follow-up)
Number of subjects: 196
Study 24504872 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive cardiac rehabilitation
Number of subjects: 196
Study 24504872 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 196
Study 24168879 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief targeted prevention intervention (BPI)
Number of subjects: 104
Study 24168879 — intervention group
Group type: COMPARATOR
Intervention: Enhanced standard care (ESC)
Number of subjects: 104
Study 20641058 — intervention group
Group type: EXPERIMENTAL
Intervention: Red ginseng extract (3 g/day)
Number of subjects: 50
Study 19675479 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic stretching
Number of subjects: 24
Study 19675479 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 24
Study 19675479 — intervention group
Group type: EXPERIMENTAL
Intervention: Light aerobic activity
Number of subjects: 24
Study 19675479 — intervention group
Group type: COMPARATOR
Intervention: Light aerobic cycling (as part of warm-up)
Number of subjects: 24
Study 17454329 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak flow monitoring (PFM)
Number of subjects: 77
Study 15061827 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine treatment for 12 months
Number of subjects: 11
Study 15061827 — intervention group
Group type: COMPARATOR
Intervention: Untreated Alzheimer's disease patients (n = 21)
Number of subjects: 11
Study 15061827 — intervention group
Group type: COMPARATOR
Intervention: Untreated mild cognitive impairment patients (n = 22)
Number of subjects: 11
Study 15061827 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine treatment
Number of subjects: 11
Study 11258692 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled anti-inflammatory medication (inhaled steroids)
Number of subjects: 315
Study 11258692 — intervention group
Group type: EXPERIMENTAL
Intervention: Action plan for asthma management
Number of subjects: 315
Study 11258692 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluation of tobacco use
Number of subjects: 315
Study 11258692 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluation of environmental triggers (pets and mites)
Number of subjects: 315
Study 11258692 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergy skin testing or RAST
Number of subjects: 315
Study 11770189 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg per day for 6 months)
Number of subjects: 1008
Study 11770189 — intervention group
Group type: COMPARATOR
Intervention: Continuous combined hormone replacement therapy (ccHRT: 2 mg estradiol and 1 mg norethisterone acetate per day for 6 months)
Number of subjects: 1008
Study 9315063 — intervention group
Group type: EXPERIMENTAL
Intervention: Short stay surgery (SSS)
Number of subjects: 246
Study 9315063 — intervention group
Group type: COMPARATOR
Intervention: Conventional stay surgery (CSS)
Number of subjects: 246
Study 8298708 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutramigen (casein hydrolysate)
Number of subjects: 158
Study 8298708 — intervention group
Group type: EXPERIMENTAL
Intervention: Profylac (ultrafiltrated whey hydrolysate)
Number of subjects: 158
Study 8298708 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 158
Study 8298708 — intervention group
Group type: COMPARATOR
Intervention: Control (breastmilk with cow milk ingestion by mother)
Number of subjects: 158
Study 3468226 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen 650 mg
Number of subjects: 45
Study 3468226 — intervention group
Group type: EXPERIMENTAL
Intervention: Propoxyphene napsylate 100 mg
Number of subjects: 45
Study 3468226 — intervention group
Group type: EXPERIMENTAL
Intervention: Propoxyphene napsylate 100 mg + Acetaminophen 650 mg
Number of subjects: 45
Study 3468226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 2199415 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose antibiotic prophylaxis for contaminated head and neck cases and endonasal sinus surgery
Number of subjects: 0
Study 2199415 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis for most clean cases
Number of subjects: 0
Study 2199415 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for wound infection
Number of subjects: 0
Study 2199415 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous radiotherapy
Number of subjects: 0
Study 31902533 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressed lithium disilicate crowns (CP)
Number of subjects: 82
Study 31902533 — intervention group
Group type: EXPERIMENTAL
Intervention: Veneered pressed lithium disilicate crowns (CV)
Number of subjects: 82
Study 31902533 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided design and computer-aided manufacturing (CAD-CAM) lithium disilicate crowns (CC)
Number of subjects: 82
Study 31902533 — intervention group
Group type: COMPARATOR
Intervention: Metal-ceramic fixed partial dentures (FPDM)
Number of subjects: 82